Since April 18, 2023, the United States Patent and Trademark Office (USPTO) has been issuing and publishing patent grants ...

Atossa Therapeutics (ATOS) announced that the United States Patent and Trademark Office has granted a new patent directed to enteric oral ...

Fifth issued patent in the U.S. for QTORIN™ rapamycin with anticipated patent life extending into 2038 QTORIN™ rapamycin has ...

The issuance of this patent marks another key milestone as FluidForm Bio continues to build a strong and defensible IP portfolio and extend its leadership in bioprinted regenerative medicine. The ...

There are many valuable benefits of registering one’s trademark with the United States Patent and Trademark Office (USPTO). A cursory Internet ...

On Wednesday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a new patent related to ...

GM has filed a patent application for a power-operated seat armrest system, potentially offering enhanced comfort for ...

Nexalin’s method aims to treat substance use disorders by stimulating neural pathways linked to addiction and withdrawal ...

today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a new patent related to the Company's innovative breast cancer vaccine technology.

Unfortunately, according to a report by The Athletic, the U.S. Patent and Trademark Office has refused all six names from the ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and ...